Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Myelodysplastic Syndromes and PTPN11[original query] |
---|
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. British journal of haematology 2010 Nov 151 (4): 365-75. Gelsi-Boyer Véronique, Trouplin Virginie, Roquain Julien, Adélaïde José, Carbuccia Nadine, Esterni Benjamin, Finetti Pascal, Murati Anne, Arnoulet Christine, Zerazhi Hacène, Fezoui Hacène, Tadrist Zoulika, Nezri Meyer, Chaffanet Max, Mozziconacci Marie-Joëlle, Vey Norbert, Birnbaum Dani |
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases. Leukemia research 2015 Mar 39 (3): 348-54. Ok Chi Young, Patel Keyur P, Garcia-Manero Guillermo, Routbort Mark J, Fu Bin, Tang Guilin, Goswami Maitrayee, Singh Rajesh, Kanagal-Shamanna Rashmi, Pierce Sherry A, Young Ken H, Kantarjian Hagop M, Medeiros L Jeffrey, Luthra Rajyalakshmi, Wang Sa |
Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia. American journal of hematology 2017 Mar . Patnaik Mrinal M, Barraco Daniela, Lasho Terra L, Finke Christy M, Reichard Kaaren, Hoversten Katherine P, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
What biologic factors predict for transformation to AML? Best practice & research. Clinical haematology 2018 11 31 (4): 341-345. Bejar Rafa |
Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation. Hematology (Amsterdam, Netherlands) 2020 6 25 (1): 211-218. Wang Kai, Zhou Feng, Cai Xiaohui, Chao Hongying, Zhang Ri, Chen Suni |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: